Back to Fosbu V Tablet (Sofosbuvir + Velpatasvir)

Fosbu V (Sofosbuvir + Velpatasvir) Side Effects in Pakistan

Complete guide to Fosbu V (Sofosbuvir + Velpatasvir) side effects — from common effects to serious warnings. This page contains essential information especially about the amiodarone interaction and HBV reactivation.

Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated:

Side Effects

Quick Answer

Common side effects of Fosbu V (Sofosbuvir + Velpatasvir) include headache, fatigue, and nausea — usually mild. A critical risk: combining Fosbu V with amiodarone can cause fatal bradycardia (dangerously slow heart rate). HBV reactivation and liver decompensation signs also require immediate attention. Report any new or worsening symptoms to your hepatologist without delay.

Side Effects at a Glance

Common

  • Headache (sar dard)
  • Fatigue (thakaan / kamzori)
  • Nausea (matlii)
  • Insomnia — especially with Ribavirin
  • Rash — in Ribavirin combination
  • Anaemia — in Ribavirin combination

Serious — See a Doctor

  • Severe bradycardia / cardiac arrest — with amiodarone (FATAL risk)
  • HBV reactivation — worsening jaundice, dark urine, abdominal pain
  • Liver decompensation — extreme fatigue, confusion (hepatic encephalopathy), ascites
  • Severe anaemia — in Ribavirin combination; pallor and breathlessness

When to See a Doctor Immediately

  • Heart rate suddenly slows or becomes irregular — EMERGENCY especially with amiodarone history
  • Worsening jaundice — sign of HBV reactivation or liver failure
  • Confusion, extreme fatigue, or fluid in abdomen (ascites) — signs of liver decompensation
  • Severe shortness of breath or pallor — sign of anaemia in Ribavirin combination
  • Rash that is spreading or accompanied by fever

Fosbu V (Sofosbuvir + Velpatasvir) Side Effects (Nuksanat)

Fosbu V (Sofosbuvir + Velpatasvir) is well-tolerated by most patients when taken at the correct dose. However there are some important and serious risks — especially the amiodarone interaction and HBV reactivation — which every patient needs to know about.

CRITICAL WARNING (Lazmi Ihtiyat)

> Never take Fosbu V with amiodarone. Fatal bradycardia has been reported with Sofosbuvir-based regimens taken alongside amiodarone. This is a life-threatening emergency. If you are using amiodarone, inform your hepatologist immediately.

Common Side Effects (Aam Nuksanat)

  • Headache (sar dard)
  • Fatigue (thakaan / kamzori)
  • Nausea (matlii)
  • Additional with Ribavirin combo: anaemia, rash, insomnia

These side effects are generally mild and are often more pronounced in the first week of treatment, then improve. If they continue, inform your hepatologist.

Serious Side Effects (Sanjeedah Nuksanat)

  • Severe bradycardia / cardiac arrest — contact EMERGENCY immediately
  • HBV reactivation — worsening jaundice, dark urine, abdominal pain — see a doctor immediately
  • Liver decompensation — extreme fatigue, confusion (hepatic encephalopathy), fluid in abdomen (ascites) — see a doctor immediately
  • Severe anaemia — pallor, breathlessness — inform your doctor

When to See a Doctor (Kab Doctor Se Milna Zaroori Hai)

  • Heart rate suddenly slows or becomes irregular — EMERGENCY (especially with amiodarone history)
  • Worsening jaundice
  • Confusion, extreme fatigue, or fluid in abdomen
  • Severe shortness of breath or pallor
  • Rash that is spreading or accompanied by fever

Warnings and Precautions (Ihtiyat)

  • Amiodarone — CONTRAINDICATED — never take together
  • HBV screening — mandatory BEFORE starting treatment
  • Teratogenicity with Ribavirin — both men and women must use contraception for 6 months after completing Ribavirin

Side Effects Summary Table

TypeSide EffectAction
CommonHeadacheMonitor / inform doctor if persistent
CommonFatigueMonitor / inform doctor if severe
CommonNauseaTake after food; inform doctor
Common (Ribavirin)AnaemiaGet regular blood count checks
SeriousBradycardiaGO TO EMERGENCY IMMEDIATELY
SeriousHBV ReactivationSee a doctor immediately
SeriousLiver DecompensationSee a doctor immediately

Reporting Side Effects

If you notice any unexpected side effect, report it on the DRAP pharmacovigilance portal: https://www.dra.gov.pk/pharmacovigilance

The information in this guide is for educational purposes only. Contact your hepatologist or pharmacist immediately if any side effect is noticed.

Frequently Asked Questions

Sofosbuvir velpatasvir ke side effects kya hain?

Common side effects include headache, fatigue, and nausea — these are mostly mild. Serious risk: when taken with amiodarone, the heart rate can slow dangerously (bradycardia) — this can be fatal. Contact your hepatologist immediately for any new symptom.

Kya Fosbu V amiodarone ke saath safe hai?

NO — the combination of Fosbu V and amiodarone is CONTRAINDICATED. It can cause fatal bradycardia, which can also lead to cardiac arrest. If you are taking amiodarone or have ever taken it, inform your hepatologist immediately.

HBV reactivation kya hota hai aur kab hota hai?

HBV (Hepatitis B) reactivation occurs when a latent Hepatitis B infection becomes active again during HCV treatment. Signs: worsening jaundice, dark urine, extreme fatigue. This is why HBV screening before treatment is mandatory. Preventive antiviral cover can be given to HBV carriers.

Ribavirin ke saath kaun se extra side effects hote hain?

Ribavirin adds risk of anaemia, rash, insomnia, and irritability. Anaemia can be severe — regular blood counts are necessary. Ribavirin is also teratogenic — both men and women must use effective contraception for 6 months after completing Ribavirin.

Fosbu V liver ya kidney par kya asar karta hai?

Fosbu V itself is mostly liver-safe but signs of liver decompensation should be monitored — extreme fatigue, confusion, ascites. Dose adjustment is not necessary for mild-to-moderate renal impairment; seek specialist advice for severe renal disease.

Sources

  1. DRAP Registered Products Database Drug Regulatory Authority of Pakistan
  2. WHO Model List of Essential Medicines, 23rd ed. (2023) World Health Organization
  3. British National Formulary (BNF) BMJ Group & Pharmaceutical Press

Medical disclaimer

This page is for educational use only and does not replace professional medical advice. Always confirm diagnosis, dose, and interactions with a qualified doctor or pharmacist before starting or changing any medicine.